MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $226,000 | -82.6% | 12,446 | -73.5% | 0.00% | -75.0% |
| Q4 2021 | $1,297,000 | -54.9% | 47,000 | -47.2% | 0.00% | -60.0% |
| Q3 2021 | $2,874,000 | +250.9% | 89,000 | +115.0% | 0.01% | +233.3% |
| Q4 2020 | $819,000 | +78.0% | 41,400 | +17.5% | 0.00% | +50.0% |
| Q3 2020 | $460,000 | -15.1% | 35,237 | -26.4% | 0.00% | -33.3% |
| Q2 2020 | $542,000 | -72.8% | 47,873 | -65.6% | 0.00% | -80.0% |
| Q1 2020 | $1,993,000 | -5.2% | 139,242 | +80.4% | 0.02% | 0.0% |
| Q4 2019 | $2,102,000 | +70.6% | 77,200 | +79.5% | 0.02% | +50.0% |
| Q3 2019 | $1,232,000 | +102.3% | 43,000 | +96.2% | 0.01% | +100.0% |
| Q2 2019 | $609,000 | -29.1% | 21,914 | -15.3% | 0.01% | -16.7% |
| Q1 2019 | $859,000 | -71.4% | 25,868 | -75.0% | 0.01% | -72.7% |
| Q4 2018 | $3,006,000 | -1.2% | 103,387 | +56.2% | 0.02% | +37.5% |
| Q3 2018 | $3,044,000 | +48.1% | 66,183 | +20.3% | 0.02% | +60.0% |
| Q2 2018 | $2,056,000 | +767.5% | 55,019 | +587.7% | 0.01% | +900.0% |
| Q1 2018 | $237,000 | -40.9% | 8,000 | -31.6% | 0.00% | -50.0% |
| Q4 2017 | $401,000 | -31.3% | 11,700 | -27.3% | 0.00% | -33.3% |
| Q3 2017 | $584,000 | -69.5% | 16,100 | -78.2% | 0.00% | -75.0% |
| Q2 2017 | $1,913,000 | +271.5% | 74,000 | +177.2% | 0.01% | +200.0% |
| Q1 2017 | $515,000 | -86.2% | 26,700 | -88.0% | 0.00% | -84.6% |
| Q4 2016 | $3,723,000 | +92975.0% | 223,365 | +111582.5% | 0.03% | – |
| Q3 2016 | $4,000 | -99.7% | 200 | -99.6% | 0.00% | -100.0% |
| Q2 2016 | $1,595,000 | +1072.8% | 52,142 | +1338.4% | 0.01% | +1000.0% |
| Q1 2016 | $136,000 | +60.0% | 3,625 | +82.7% | 0.00% | 0.0% |
| Q4 2015 | $85,000 | -98.1% | 1,984 | -98.3% | 0.00% | -97.4% |
| Q3 2015 | $4,405,000 | +10912.5% | 117,585 | +9781.1% | 0.04% | – |
| Q2 2015 | $40,000 | -16.7% | 1,190 | -16.1% | 0.00% | – |
| Q4 2014 | $48,000 | +108.7% | 1,418 | +136.3% | 0.00% | – |
| Q2 2014 | $23,000 | +76.9% | 600 | +50.0% | 0.00% | – |
| Q1 2014 | $13,000 | -99.6% | 400 | -99.7% | 0.00% | -100.0% |
| Q2 2013 | $3,142,000 | – | 116,976 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |